FDA Approves Plasma Replacement Therapy for von Willebrand Disease
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




FDA Approves Plasma Replacement Therapy for von Willebrand Disease

NEW YORK -- January 13, 2009 -- The US Food and Drug Administration (FDA) has approved a high-purity, double virus inactivated von Willebrand Factor/Coagulation Factor VIII Concentrate (Human [Wilate]) for the treatment of spontaneous and trauma-induced bleeding episodes in patients with all types of von Willebrand disease (VWD).

The double virus inactivated VWF/FVIII, high-purity concentrate is exclusively derived from large pools of human plasma collected in FDA approved plasma donation centres

The FDA is based on 4 prospective clinical trials demonstrating the safety, tolerability, and haemostatic efficacy of the double virus inactivated VWF/FVIII, high-purity concentrate in the treatment of acute bleeding episodes and prophylaxis in patients with various types of VWD.

Using objective criteria, the replacement therapy was observed in 1,068 bleeding episodes and determined to be successful between 84% and 93% of the time with results varying dependent on patient type.

SOURCE: Octapharma

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities